SigmaR1 has been found to be upregulated in a number of cancers including lung cancer, breast cancer, glioblastoma, esophageal cancer, pancreatic cancer, prostate cancer, and liver cancer [31,32,33,34,35,36,37,38]. Here, SIGMAR1 is linked to breast carcinoma.